The South Korea healthcare cold chain logistics market size is expected to exhibit a growth rate (CAGR) of 3.87% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) | 3.87% |
Healthcare cold chain logistics help maintain the integrity of temperature-sensitive medical products like vaccines during transportation. They rely on a digital system for monitoring the cold chain and logistics at service delivery points and generating actionable data, which is provided to a designated person at each level of the cold chain. Nowadays, healthcare service providers require real-time monitoring and reporting for storing and transporting biological products. As a result, the demand for advanced healthcare cold chain logistics systems is rising in South Korea.
The rising need for vaccines and biopharmaceuticals due to the increasing prevalence of infectious and chronic disorders represents one of the key factors catalyzing the demand for healthcare cold chain logistics in South Korea. Apart from this, the integration of augmented reality (AR), blockchain, and the internet of things (IoT) with cold chain monitoring systems to offer predictive alerts of warehouse management, transportation, and delivery is driving the market in the country. Furthermore, the escalating demand for transporting highly sophisticated clinical trial specimens and biologics is contributing to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the South Korea healthcare cold chain logistics market report, along with forecasts at the country and regional levels from 2024-2032. Our report has categorized the market based on product and segment.
Breakup by Product:
Breakup by Segment:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Segment Coverage | Product, Segment, Region |
Region Covered | East, West, Southwest, Southeast |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the South Korea healthcare cold chain logistics market to exhibit a CAGR of 3.87% during 2024-2032.
The rising demand for delivering clinical trial specimens and biologics is primarily driving the South Korea healthcare cold chain logistics market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of healthcare cold chain logistics across the nation, to maintain the integrity of temperature-sensitive medical products, including vaccines, during their transportation.
Based on the product, the South Korea healthcare cold chain logistics has been divided into biopharmaceuticals, vaccines, and clinical trials. Among these, vaccines currently exhibit a clear dominance in the market.
Based on the segment, the South Korea healthcare cold chain logistics can be segmented into transportation, packaging, and instrumentation. Currently, transportation holds the majority of the total market share.
On a regional level, the market has been classified into East, West, Southwest, and Southeast.